Americas Gold and Silver Corporation (USA:CA) M&A Call Transcript — Neutral

USA  USAS   Seeking Alpha — November 13, 2025

Americas Gold and Silver Corporation ( USA:CA ) M&A Call November 13, 2025 10:00 AM EST Company Participants Paul Huet - CEO & Chairman of the Board Oliver Turner Conference Call Participants Heiko Ihle - H.C. Wainwright & Co, LLC, Research Division Justin Chan - SCP Resource Finance LP, Research Division Presentation Operator Ladies and gentlemen, thank you for standing by.

image for news Americas Gold and Silver Corporation (USA:CA) M&A Call Transcript

TAT Technologies Ltd. (TATT) Q3 2025 Earnings Call Transcript — Neutral

TATT   Seeking Alpha — November 13, 2025

TAT Technologies Ltd. ( TATT ) Q3 2025 Earnings Call November 13, 2025 8:30 AM EST Company Participants Igal Zamir - CEO, President & Director Ehud Ben-Yair - Chief Financial Officer Conference Call Participants Matthew Chesler - FNK IR LLC Michael Ciarmoli - Truist Securities, Inc., Research Division Presentation Matthew Chesler FNK IR LLC [Audio Gap] A U.S. based Investor Relations firm supporting Eran Yunger, TAT's Internal Head of Investor Relations.

image for news TAT Technologies Ltd. (TATT) Q3 2025 Earnings Call Transcript

New York, New York--(Newsfile Corp. - November 13, 2025) - If you suffered a loss on your Cytokinetics, Incorporated (NASDAQ: CYTK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/cytokinetics-incorporated-lawsuit-submission-form-2?prid=177266&wire=5&utm_campaign=2 or contact Joseph E. Levi, Esq.

image for news Securities Lawsuit Alert: Cytokinetics, Incorporated (CYTK) Investors - Contact Levi & Korsinsky Before November 17, 2025

Nexxen International Ltd. (NEXN) Q3 2025 Earnings Call Transcript — Neutral

NEXN   Seeking Alpha — November 13, 2025

Nexxen International Ltd. ( NEXN ) Q3 2025 Earnings Call November 13, 2025 9:00 AM EST Company Participants William Eckert - Vice President of Investor Relations Ofer Druker - CEO & Executive Director Sagi Niri - Chief Financial Officer Conference Call Participants Matthew Swanson - RBC Capital Markets, Research Division Jason Kreyer - Craig-Hallum Capital Group LLC, Research Division Laura Martin - Needham & Company, LLC, Research Division Andrew Marok - Raymond James & Associates, Inc., Research Division Matthew Condon - Citizens JMP Securities, LLC, Research Division Barton Crockett - Rosenblatt Securities Inc., Research Division Tyler DiMatteo - BTIG, LLC, …

image for news Nexxen International Ltd. (NEXN) Q3 2025 Earnings Call Transcript

GoHealth, Inc. (GOCO) Q3 2025 Earnings Call Transcript — Neutral

GOCO   Seeking Alpha — November 13, 2025

GoHealth, Inc. ( GOCO ) Q3 2025 Earnings Call November 13, 2025 8:00 AM EST Company Participants John Shave - Vice President of Investor Relations Vijay Kotte - CEO & Director Conference Call Participants Robert McGuire - Granite Research, LLC Patrick McCann - NOBLE Capital Markets, Inc., Research Division Benjamin Hendrix - RBC Capital Markets, Research Division James Sidoti - Sidoti & Company, LLC David Storms - Stonegate Capital Partners, Inc., Research Division Presentation Operator Good day, and welcome to the GoHealth Third Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note, this event is being recorded.

image for news GoHealth, Inc. (GOCO) Q3 2025 Earnings Call Transcript

DarioHealth Corp. (DRIO) Q3 2025 Earnings Call Transcript — Neutral

DRIO   Seeking Alpha — November 13, 2025

DarioHealth Corp. ( DRIO ) Q3 2025 Earnings Call November 13, 2025 8:30 AM EST Company Participants Zoe Harrison Erez Raphael - CEO & Director Steven Nelson - President & Chief Commercial Officer Chen Franco-Yehuda - CFO, Treasurer & Secretary Conference Call Participants Lucas Romanski - TD Cowen, Research Division Theodore O'Neill - Litchfield Hills Research, LLC Presentation Operator Good morning, ladies and gentlemen, and welcome to the DarioHealth Third Quarter 2025 Results Conference Call. [Operator Instructions] This call is being recorded on Thursday, November 13, 2025.

image for news DarioHealth Corp. (DRIO) Q3 2025 Earnings Call Transcript

Total Energy Services Inc. (TOT:CA) Q3 2025 Earnings Call Transcript — Neutral

TOT  TOTZF   Seeking Alpha — November 13, 2025

Total Energy Services Inc. ( TOT:CA ) Q3 2025 Earnings Call November 13, 2025 11:00 AM EST Company Participants Daniel Halyk - President, CEO & Director Yulia Gorbach - VP of Finance & CFO Conference Call Participants Tim Monachello - ATB Capital Markets Inc., Research Division Josef Schachter - Schachter Energy Research Services Inc. Paul Starkman Presentation Operator Hello, and thank you for standing by. My name is Regina, and I will be your conference operator today.

image for news Total Energy Services Inc. (TOT:CA) Q3 2025 Earnings Call Transcript

TWFG, Inc. (TWFG) Q3 2025 Earnings Call Transcript — Neutral

TWFG   Seeking Alpha — November 13, 2025

TWFG, Inc. ( TWFG ) Q3 2025 Earnings Call November 13, 2025 10:00 AM EST Company Participants Richard Bunch - Chairman, CEO & President Janice Zwinggi - Chief Financial Officer Conference Call Participants Thomas Mcjoynt-Griffith - Keefe, Bruyette, & Woods, Inc., Research Division Jon Paul Newsome - Piper Sandler & Co., Research Division Pablo Singzon - JPMorgan Chase & Co, Research Division Brian Meredith - UBS Investment Bank, Research Division Charles Lederer - BMO Capital Markets Equity Research Presentation Operator Good morning, and welcome to TWFG's Third Quarter 2025 Earnings Conference Call. [Operator Instructions] As a reminder, today's call may …

image for news TWFG, Inc. (TWFG) Q3 2025 Earnings Call Transcript

Pelthos Therapeutics Inc. (PTHS) Q3 2025 Earnings Call Transcript — Neutral

PTHS   Seeking Alpha — November 13, 2025

Pelthos Therapeutics Inc. ( PTHS ) Q3 2025 Earnings Call November 13, 2025 8:00 AM EST Company Participants Mike Moyer Scott Plesha - CEO, President & Director Sai Rangarao Francis Knuettel - Chief Financial Officer Conference Call Participants Jeffrey Jones - Oppenheimer & Co. Inc., Research Division James Molloy - Alliance Global Partners, Research Division Presentation Operator Greetings, and welcome to the Pelthos Therapeutics Third Quarter 2025 Financial Results Conference Call. [Operator Instructions] Please note, this conference is being recorded.

image for news Pelthos Therapeutics Inc. (PTHS) Q3 2025 Earnings Call Transcript

Valmont Industries, Inc. ( VMI ) Baird 55th Annual Global Industrial Conference November 13, 2025 12:25 PM EST Company Participants Renee Campbell - Senior VP of Investor Relations & Treasurer Avner Applbaum - CEO, President & Director Conference Call Participants Trent Meyer Presentation Trent Meyer All right. Good morning, everyone.

image for news Valmont Industries, Inc. (VMI) Presents at Baird 55th Annual Global Industrial Conference Transcript

Cybin Inc. (CYBN) Q2 2026 Earnings Call Transcript — Neutral

CYBN   Seeking Alpha — November 13, 2025

Cybin Inc. ( CYBN ) Q2 2026 Earnings Call November 13, 2025 8:00 AM EST Company Participants Eric So - Co-Founder, Interim CEO, President & Executive Chairman Amir Inamdar - Chief Medical Officer Greg Cavers - Chief Financial Officer George Tziras Conference Call Participants Sarah James Patrick Trucchio - H.C. Wainwright & Co, LLC, Research Division Laura Suriel Eddie Hickman - Guggenheim Securities, LLC, Research Division Elemer Piros - Lucid Capital Markets, LLC, Research Division Sumant Kulkarni - Canaccord Genuity Corp., Research Division Presentation Eric So Co-Founder, Interim CEO, President & Executive Chairman Good morning, and thank you for joining …

image for news Cybin Inc. (CYBN) Q2 2026 Earnings Call Transcript

Aldeyra Therapeutics, Inc. ( ALDX ) Discusses Expansion of RASP Platform Into CNS Diseases and Update on Reproxalap for Dry Eye November 13, 2025 8:00 AM EST Company Participants Laura Nichols - Operations Manager Todd Brady - CEO, President & Director Adam Lazorchak Conference Call Participants Thomas Shrader - BTIG, LLC, Research Division Catherine Novack - JonesTrading Institutional Services, LLC, Research Division Clara Dong Yale Jen Presentation Operator Hello, and welcome, everyone, to the Aldeyra Therapeutics 2025 Research and Development Update Webcast. My name is Becky, and I'll be your operator today.

image for news Aldeyra Therapeutics, Inc. (ALDX) Discusses Expansion of RASP Platform Into CNS Diseases and Update on Reproxalap for Dry Eye Transcript

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Perrigo Company plc (“Perrigo” or the “Company”) (NYSE: PRGO) investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN PERRIGO COMPANY PLC (PRGO), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. Contact the Law Offices of Howard G. Smith to discuss your legal rights by ema.

image for news Perrigo Company plc (PRGO) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

Spectrum Brands' Q4 Earnings Beat Estimates, Organic Sales Dip 6.6% Y/Y — Neutral

SPB   Zacks Investment Research — November 13, 2025

SPB posts mixed Q4 results as earnings surge on lower taxes but sales slip amid weak volumes and tariffs.

image for news Spectrum Brands' Q4 Earnings Beat Estimates, Organic Sales Dip 6.6% Y/Y

Global Water Resources, Inc. (GWRS) Q3 2025 Earnings Call Transcript — Neutral

GWRS   Seeking Alpha — November 13, 2025

Global Water Resources, Inc. ( GWRS ) Q3 2025 Earnings Call November 13, 2025 1:00 PM EST Company Participants Kyle Upchurch - Controller Ron Fleming - Chairman, CEO & President Michael Liebman - Senior VP, CFO & Corporate Secretary Christopher Krygier - Chief Operating Officer Conference Call Participants Gerard Sweeney - ROTH Capital Partners, LLC, Research Division Matvey Tayts - Freedom Broker, Research Division Presentation Operator Greetings, ladies and gentlemen. Thank you for standing by.

image for news Global Water Resources, Inc. (GWRS) Q3 2025 Earnings Call Transcript

Corby Spirit and Wine Limited ( CSW.A:CA ) Shareholder/Analyst Call November 13, 2025 11:00 AM EST Company Participants Lucio Di Clemente Marc Valencia - General Counsel, Corporate Secretary & VP of Public Affairs Jordan Giurlanda Nicolas Krantz - President, CEO & Director Juan Alonso - VP, CFO & Director Presentation Lucio Di Clemente Good morning, ladies and gentlemen. My name is Lucio Di Clemente, Chair of the Board of Directors of Corby Spirit and Wine Limited, and it is my pleasure to welcome you to our Annual Meeting of Shareholders.

image for news Corby Spirit and Wine Limited (CSW.A:CA) Shareholder/Analyst Call Prepared Remarks Transcript

STXS Secures FDA Approval for GenesisX to Broaden Surgical Robotics — Positive

STXS   Zacks Investment Research — November 13, 2025

Stereotaxis wins FDA clearance for GenesisX, a streamlined robotic system aimed at boosting hospital adoption and accelerating growth.

image for news STXS Secures FDA Approval for GenesisX to Broaden Surgical Robotics

Is ARM Stock Still a Smart Bet After Its Record Q2 Results? — Positive

ARM   Zacks Investment Research — November 13, 2025

ARM posts record fiscal Q2 with surging AI-driven revenue and partnerships, but lofty valuation tempers investor enthusiasm.

image for news Is ARM Stock Still a Smart Bet After Its Record Q2 Results?

BDX Unveils Portable PureWick System for On-the-Go Incontinence Care — Positive

BDX   Zacks Investment Research — November 13, 2025

BD expands its PureWick line with a portable system built for discreet, mobile incontinence care, aiming to deepen its home-care reach.

image for news BDX Unveils Portable PureWick System for On-the-Go Incontinence Care

SALT LAKE CITY, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Security National Financial Corporation (SNFC) (NASDAQ symbol "SNFCA") announced financial results for the quarter ended September 30, 2025. For the three months ended September 30, 2025, SNFC's after tax earnings decreased 34% from $11,831,000 in 2024 to $7,815,000 in 2025. For the nine months ended September 30, 2025, after tax earnings decreased 30% to $18,866,000 from $26,578,000 in 2024.

image for news Security National Financial Corporation Reports Financial Results for the Quarter Ended September 30, 2025